Compare MAIA & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAIA | BTTC |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9M | 40.5M |
| IPO Year | 2022 | N/A |
| Metric | MAIA | BTTC |
|---|---|---|
| Price | $1.12 | $3.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 224.1K | 31.8K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | N/A | ★ $2,719,480.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.34 |
| Revenue Growth | N/A | ★ 2.04 |
| 52 Week Low | $0.87 | $2.81 |
| 52 Week High | $2.74 | $39.00 |
| Indicator | MAIA | BTTC |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | N/A |
| Support Level | $0.87 | N/A |
| Resistance Level | $1.09 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 86.21 | 0.00 |
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
Black Titan Corp is engaged in software implementation and training. It provides consulting services and Human Resource and Payroll solutions.